 0 Table of Contents |
  1 Home |
  2 Background |
  3 Data flow |
  4 FHIR asynchronous validation |
  5 Models |
  6 Terminology |
  7 Downloads |
  8 Artifacts Summary |
   8.1 BCR Breast Tumour Supplement — Bijlage 55 vervolg 1 (Logical Model) |
   8.2 BCR Cancer Case (Logical Model) |
   8.3 BCR Cancer Registration Form — Bijlage 55 (Logical Model) |
   8.4 BCR CHP Breast Sample (Logical Model) |
   8.5 BCR CHP Cervix Sample (Logical Model) |
   8.6 BCR CHP Colorectal Sample (Logical Model) |
   8.7 BCR CHP Sample (Abstract Base Logical Model) |
   8.8 BCR Follow-Up Form — Bijlage 55 vervolg 3 (Logical Model) |
   8.9 BCR MOC Form — Bijlage 55 vervolg 2 (Logical Model) |
   8.10 BCR Registration Task |
   8.11 BCR Validation Outcome |
   8.12 BCR Validation Task |
   8.13 BCR Basis of Diagnosis |
   8.14 BCR Belgian Region |
   8.15 BCR Breast Tumour Sequence |
   8.16 BCR CHP Data Confidence Level |
   8.17 BCR CHP Sample Category |
   8.18 BCR Clinical Trial Indicator |
   8.19 BCR Differentiation Grade |
   8.20 BCR ER / PR Result |
   8.21 BCR Follow-Up MOC Reason |
   8.22 BCR Gene Mutation Result |
   8.23 BCR HER2 Combined (IHC + ISH) Result |
   8.24 BCR HER2 IHC Score Result |
   8.25 BCR HPV Genotype |
   8.26 BCR HPV Test Result |
   8.27 BCR ICD-10 |
   8.28 BCR ICD-O-3 Behaviour (digit only) |
   8.29 BCR ICD-O-3 Morphology |
   8.30 BCR ICD-O-3 Topography |
   8.31 BCR Intended Treatment Code |
   8.32 BCR Ki-67 Result |
   8.33 BCR Laterality |
   8.34 BCR Lymph Node Location |
   8.35 BCR Menopausal Status |
   8.36 BCR MOC Reason |
   8.37 BCR Molecular Marker |
   8.38 BCR Molecular Marker Result (union) |
   8.39 BCR Other Stage Classification |
   8.40 BCR Recurrence Type |
   8.41 BCR Sex at Birth |
   8.42 BCR Specimen Quality |
   8.43 BCR Submission Intent |
   8.44 BCR Task Code |
   8.45 BCR Task Input/Output Type |
   8.46 BCR Task Status Reason |
   8.47 BCR Treatment Chronology Code |
   8.48 BCR Vital Status |
   8.49 BCR WHO Performance Score |
   8.50 BCR Basis of Diagnosis |
   8.51 BCR Belgian Region |
   8.52 BCR Breast Tumour Sequence |
   8.53 BCR CHP Data Confidence Level |
   8.54 BCR CHP Sample Category |
   8.55 BCR Clinical Trial Indicator |
   8.56 BCR Diagnosis / Treatment Code |
   8.57 BCR Differentiation Grade |
   8.58 BCR Follow-Up MOC Reason |
   8.59 BCR HPV Genotype |
   8.60 BCR HPV Test Result |
   8.61 BCR ICD-O-3 Behaviour |
   8.62 BCR Laterality |
   8.63 BCR Lymph Node Location |
   8.64 BCR Menopausal Status |
   8.65 BCR MOC Reason |
   8.66 BCR Molecular Marker |
   8.67 BCR Molecular Marker Result |
   8.68 BCR Other Stage Classification |
   8.69 BCR Recurrence Type |
   8.70 BCR Specimen Quality |
   8.71 BCR Submission Intent |
   8.72 BCR Task Code |
   8.73 BCR Task Input/Output Type |
   8.74 BCR Task Status Reason |
   8.75 BCR Vital Status |
   8.76 BCR WHO Performance Score |
   8.77 Tiro Item Control |
   8.78 BCR Cancer Registration Form Questionnaire |
   8.79 BCR FHIR Validation Service |
   8.80 Belgian Cancer Registry (example) |
   8.81 Example BCR Cancer Case |
   8.82 Example BCR Patient |
   8.83 Example Cancer Case (Condition) |
   8.84 Example Oncology Hospital |
   8.85 Example Registration Task |
   8.86 Example Submitted Cancer Registration (QuestionnaireResponse) |
   8.87 Example Validation Outcome — accepted |
   8.88 Example Validation Outcome — failed |
   8.89 Example Validation Result Subscription |
   8.90 Example Validation Task — attempt 1 (failed) |
   8.91 Example Validation Task — attempt 2 (completed) |